{
    "2018-04-11": [
        [
            {
                "time": "2018-01-02",
                "original_text": "FDA Prolongs Review Date for AbbVie Endometriosis Candidate",
                "features": {
                    "keywords": [
                        "FDA",
                        "Prolongs",
                        "Review",
                        "AbbVie",
                        "Endometriosis"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Biotech Stock Roundup: Spectrum Up, Incyte Down, AveXis to Merge with Novartis",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Spectrum",
                        "Incyte",
                        "AveXis",
                        "Novartis",
                        "Merge"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Ex-Dividend Alert: Boosted its Dividend by Whopping 35%; Will Trade Ex-Dividend on April 12, 2018",
                "features": {
                    "keywords": [
                        "Ex-Dividend",
                        "Boosted",
                        "Dividend",
                        "Whopping",
                        "35%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "A Look at Eli Lillyâ€™s 1Q18 Stock Performance",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "1Q18",
                        "Stock",
                        "Performance"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "Is Gilead Sciences, Inc. (GILD) a Buy?",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "AGTC Awaits Gene Therapy Data, FDA Delays Decision On Elagolix, KPTI On Watch",
                "features": {
                    "keywords": [
                        "AGTC",
                        "Gene Therapy",
                        "FDA",
                        "Delays",
                        "Decision",
                        "Elagolix",
                        "KPTI"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}